Shannon M. Lentz

Skilled IP litigator and strategist in and out of the courtroom. Outside-the-box thinker with deep biomedical expertise. Significant experience across diverse technologies.

A versatile litigator and advisor, Shannon Lentz is trusted by clients as a strategic partner in navigating complex IP and patent issues. She approaches patent challenges and filings with a creative, business-aligned focus on crafting solutions that minimize risk while optimizing return on investment in clients’ IP portfolios.

Shannon advises clients across the life sciences and health care industries, with a practice grounded in pharmaceuticals, biologics and advanced therapeutic technologies. She has extensive experience in the highly complex and rapidly evolving field of antibody‑based therapeutics, advising clients at the cutting edge of multivalent and next‑generation antibody development as well as protecting substantial R&D investments through multipronged patent and IP strategies. Shannon also advises clients in the human tissue and regenerative medicine space, building strategies for musculoskeletal tissue grafts, soft tissue and bone‑based products, and donor‑derived biologic materials. She brings additional experience across molecular biology, chemistry, genetics, medical devices and nanomaterials.

Her experience in these areas complements her broader life science practice and reflects a deep understanding of how patent strategy intersects with scientific, regulatory and commercialization considerations across highly regulated technologies.

Shannon’s practice spans the full range of IP dispute resolution and portfolio development. She has experience challenging and defending patents through post-grant review at the U.S. Patent and Trademark Office and in federal district court. She also helps clients protect their inventions through a global patent procurement strategy. Clients rely on her judgment to take calculated risks in furtherance of their business objectives while avoiding pitfalls that can lead to costly legal challenges.

EDUCATION

J.D., 2010, University of Maryland School of Law, J.D.

B.S., 2005, University of Maryland

ADMISSIONS

District of Columbia

Maryland

U.S. Patent and Trademark Office

COMMUNITY INVOLVEMENT

RECOGNITION

Legal 500, U.S. Elite, Washington, D.C., 2026